The Safety and Immunogenicity of the BNT162b2 mRNA COVID-19 Vaccine in Japanese Patients after Allogeneic Stem Cell Transplantation

por Watanabe, Marika, Yakushijin, Kimikazu, Funakoshi, Yohei, Ohji, Goh, Hojo, Wataru, Sakai, Hironori, Saeki, Miki, Hirakawa, Yuri, Matsumoto, Sakuya, Sakai, Rina, Nagao, Shigeki, Kitao, Akihito, Miyata, Yoshiharu, Koyama, Taiji, Saito, Yasuyuki, Kawamoto, Shinichiro, Ito, Mitsuhiro, Murayama, Tohru, Matsuoka, Hiroshi, Minami, Hironobu
Publicado 2022

A Third Dose COVID-19 Vaccination in Allogeneic Hematopoietic Stem Cell Transplantation Patients

por Watanabe, Marika, Yakushijin, Kimikazu, Funakoshi, Yohei, Ohji, Goh, Ichikawa, Hiroya, Sakai, Hironori, Hojo, Wataru, Saeki, Miki, Hirakawa, Yuri, Matsumoto, Sakuya, Sakai, Rina, Nagao, Shigeki, Kitao, Akihito, Miyata, Yoshiharu, Koyama, Taiji, Saito, Yasuyuki, Kawamoto, Shinichiro, Yamamoto, Katsuya, Ito, Mitsuhiro, Murayama, Tohru, Matsuoka, Hiroshi, Minami, Hironobu
Publicado 2022

Global longitudinal strain is superior to ejection fraction for long‐term follow‐up after allogeneic hematopoietic stem cell transplantation

por Watanabe, Marika, Yakushijin, Kimikazu, Tanaka, Hidekazu, Chijiki, Ruri, Saeki, Miki, Hirakawa, Yuri, Takakura, Hidetomo, Usui, Yutaro, Ichikawa, Hiroya, Sakai, Rina, Matsumoto, Sakuya, Nagao, Shigeki, Mizutani, Yu, Kurata, Keiji, Kitao, Akihito, Miyata, Yoshiharu, Saito, Yasuyuki, Kawamoto, Shinichiro, Yamamoto, Katsuya, Ito, Mitsuhiro, Matsuoka, Hiroshi, Minami, Hironobu
Publicado 2022

Increase in Antibody Titers Following Sars-Cov-2 Vaccination Remains Limited for More Than 3 Years after Final Dose of Anti-CD20 Antibody

por Funakoshi, Yohei, Yakushijin, Kimikazu, Ohji, Goh, Sakai, Hironori, Hojo, Wataru, Watanabe, Marika, Saeki, Miki, Hirakawa, Yuri, Sakai, Rina, Matsumoto, Sakuya, Mizutani, Yu, Kitao, Akihito, Miyata, Yoshiharu, Saito, Yasuyuki, Kawamoto, Shinichiro, Katsuya, Yamamoto, Ito, Mitsuhiro, Nishimura, Meiko, Imamura, Yoshinori, Kiyota, Naomi, Matsuoka, Hiroshi, Mori, Yasuko, Minami, Hironobu
Publicado 2021

Limited increase in antibody titers following mRNA SARS-CoV-2 vaccination for more than 3 years after final dose of anti-CD20 antibody

por Funakoshi, Yohei, Yakushijin, Kimikazu, Ohji, Goh, Hojo, Wataru, Sakai, Hironori, Watanabe, Marika, Saeki, Miki, Hirakawa, Yuri, Sakai, Rina, Matsumoto, Sakuya, Mizutani, Yu, Kitao, Akihito, Miyata, Yoshiharu, Saito, Yasuyuki, Kawamoto, Shinichiro, Yamamoto, Katsuya, Ito, Mitsuhiro, Nishimura, Meiko, Imamura, Yoshinori, Kiyota, Naomi, Matsuoka, Hiroshi, Mori, Yasuko, Minami, Hironobu
Publicado 2022